Evotec SE
EVO
$4.20
-$0.02-0.47%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/25/2025
-
Accesswire
6/19/2025
-
Tickeron - Stocks
6/18/2025
-
Tickeron - Stocks
6/17/2025
-
MarketBeat
6/16/2025
-
MarketBeat
6/12/2025
-
MarketBeat
6/12/2025
-
Tickeron - Stocks
6/3/2025
-
TipRanks Financial Blog
5/31/2025
-
MarketBeat
5/29/2025
-
MarketBeat
5/28/2025
-
MarketBeat
5/25/2025
-
MarketBeat
5/24/2025
-
MarketBeat
5/24/2025
-
Tickeron - Stocks
5/24/2025
-
Tickeron - Stocks
5/15/2025
-
Tickeron - Technical Analysis
5/14/2025
-
MarketBeat
5/14/2025
-
Tickeron - Stocks
5/13/2025
-
MarketBeat
5/7/2025
-
GuruFocus
5/7/2025
-
Accesswire
5/7/2025
-
GuruFocus
5/6/2025
-
Seeking Alpha: Transcripts
5/6/2025
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 6, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
49 40 560 81 0
Address
Essener Bogen 7
Hamburg, 22419
Hamburg, 22419
Country
Year Founded
Business Description
Sector
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. It operates in two segments, Shared R&D and Just Evotec Biologics. The...
more